Related Experiment Video
Updated: Jul 19, 2026
09:57
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients
S Branford1, N C P Cross, A Hochhaus
1Division of Molecular Pathology, Institute of Medical and Veterinary Science, Adelaide, South Australia. susan.branford@imvs.sa.gov.au
Leukemia
|September 23, 2006
Summary
Optimizing real-time quantitative polymerase chain reaction (RQ-PCR) for BCR-ABL monitoring in chronic myeloid leukaemia (CML) is crucial. Harmonized methods and an International Scale improve measurement reliability for effective treatment decisions.
Area of Science:
- Oncology
- Molecular Biology
- Clinical Diagnostics
Background:
- Molecular monitoring of BCR-ABL transcripts is essential for chronic myeloid leukaemia (CML) patients undergoing imatinib therapy.
- Real-time quantitative polymerase chain reaction (RQ-PCR) is the standard technique, but requires procedural optimization for widespread clinical use.
- Standardization is needed to ensure reliable analysis for clinical decision-making.
Purpose of the Study:
- To present evidence supporting recommendations for harmonizing RQ-PCR methodologies for BCR-ABL transcript measurement.
- To advocate for the adoption of an International Scale for consistent and reliable quantification.
- To highlight the importance of procedural optimization for routine patient monitoring.
Main Methods:
- Review of evidence and supporting data for proposed harmonization recommendations.
- Emphasis on using consistent cell sources (blood or marrow) for analysis.
- Validation of PCR amplification efficiencies and implementation of quality assurance programs.
Main Results:
- Specific recommendations include standardized cell source selection and validation of amplification efficiencies.
- Quality assurance programs are vital for maintaining high-level performance.
- Adoption of an International Scale is proposed to enhance measurement consistency.
Conclusions:
- Standardized RQ-PCR methods are critical for reliable BCR-ABL measurement in CML patients.
- Consistent methodology and an International Scale improve the clinical utility of monitoring treatment response.
- Harmonization will establish RQ-PCR as the optimal method for CML treatment monitoring.
